focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Silver jumps, stocks slide as social trading roils market

Fri, 29th Jan 2021 21:32

(Adds close of U.S. markets)

* Silver prices rise on social media speculation

* J&J falls as vaccine disappoints

* Bitcoin jumps 14% after Elon Musk mention

* Treasury yields rise after inflation data

By Herbert Lash and Carolyn Cohn

NEW YORK/LONDON, Jan 29 (Reuters) - Silver prices jumped and
global equity markets sank on Friday amid a growing battle on
Wall Street between hedge funds and retail investors, while a
dispute over COVID-19 vaccine supply in Europe cooled risk
appetite.

Disappointing vaccine data from Johnson & Johnson
also hurt sentiment but the assault of retail traders using
online forums to force hedge funds to reverse short positions -
bets that stocks will fall - kept the market on edge.

Shares of GameStop Corp and AMC Entertainment
Holdings Inc surged again after Robinhood and
Interactive Brokers said they planned to ease restrictions after
imposing buying halts on Thursday.

GameStop soared 67.9% to $325 a share, five times its
closing price a week ago Friday, and AMC gained 53.7%, both in
heavy trade. AMC was one of the most active stocks on the New
York Stock Exchange. Volume on U.S. exchanges was 16.83 billion
shares, up from the 10.6 billion average in the fourth quarter.

Silver rallied and was up 2% at $26.90 an ounce,
taking gains to almost 10% since messages began to circulate on
Reddit early Thursday urging retail investors to pile into the
market and drive up prices.

Anxiety has grown as investors ask whether hedge funds will
need to liquidate other positions to address losses in stocks
they have shorted, said Michael Arone, chief investment
strategist at State Street Global Advisors in Boston.

"Once this short squeeze inevitably ends and there aren't
any more greater fools to bid up these stocks, will retail
investors get stuck holding the bag?" Arone asked.

"The unintended consequences of this potential volatility
have markets on edge as we end the week," Arone said.

Arone added that investors need to take a giant step back as
earnings are strong, the economy is improving, fiscal and
monetary policy is supportive and vaccines are rolling out.

MSCI's benchmark for global equity markets
fell 1.82% to 642.57, while Europe's broad FTSEurofirst 300
index closed down 1.95% at 1,524.1 to post its worst
weekly loss, at 3.3%, since October.

On Wall Street, the Dow Jones Industrial Average fell
2.03%, the S&P 500 lost 1.93% and the Nasdaq Composite
dropped 2%. The three indexes suffered their biggest
weekly fall since the end of October.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1.1% to post a weekly loss of 4.4%. Japan's
Nikkei fell 1.9%, recording its first weekly loss of the
year.

VACCINE DISPUTE

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca Plc offered eight million more doses of
its COVID-19 vaccine to the European Union after it unexpectedly
announced supply cuts last week. But the bloc said that was far
short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have prolonged
lockdowns and delayed expectations of an economic rebound.

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race.

The U.S. dollar retreated from its highest level since
mid-November against the Japanese yen as investors
rebalanced portfolios for month-end. The greenback slid 0.48%
against the yen and traded little changed against an index of
currencies, falling 0.002%.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc chief Elon Musk tagged the
cryptocurrency in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

U.S. Treasury yields rose, in line with those in Europe,
after data showed inflation perked up last month, while
employment costs rose, suggesting the world's largest economy is
on the mend from the devastating effects of the pandemic.

The U.S. yield curve steepened as long yields increased,
with the spread between 2-year and 10-year notes hitting 98.20
basis points, the widest in about a week.

The 10-year U.S. Treasury note rose 2.1 basis
points to yield 1.0757%.

Oil prices traded mixed as demand concerns caused by new
coronavirus variants and slow vaccine rollouts offset a cut in
Saudi Arabian oil supply and falling U.S. oil inventories.

Brent crude futures settled up 35 cents at $55.88 a
barrel. U.S. crude futures fell 14 cents to settle at
$52.20 a barrel.

Spot gold prices rose 0.16% to $1,843.31 an ounce.
U.S. gold futures settled up 0.5% to $1,850.30 an ounce.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Will Dunham, Richard Pullin, Ana
Nicolaci da Costa, William Maclean, Larry King, Dan Grebler and
Richard Chang)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.